According to recent reports, a prominent transplant surgeon in Texas is under investigation for falsifying patient data in a government transplant waiting list. The surgeon, identified as Dr. Steve Bynon, oversaw both the liver and kidney transplant programs at Memorial Hermann-Texas Medical Center.

The hospital halted its liver transplant program on April 3 after finding “irregularities” with donor acceptance criteria, which may have prevented patients from receiving lifesaving liver transplants. The hospital also halted its kidney transplant program, citing the need to evaluate a new physician leadership structure.

According to media reports and hospital statements, Bynon allegedly changed patient records to make it appear as though certain patients were not eligible for transplants. These changes may have been made to prevent his own patients from receiving transplants, which could have resulted in their deaths or poor outcomes.

Officials at Memorial Hermann told the New York Times that a doctor in its liver transplant program had admitted to changing patient records, and that doctor was identified as Bynon. However, when reporters for the Times reached Bynon by phone, he did not confirm the allegations and referred further questions to UTHealth Houston, where he is also a surgical transplant director.

In response to the allegations, UTHealth Houston released a statement defending Bynon, saying that he is “an exceptionally talented and caring physician” with survival rates and outcomes for his transplant patients that are among the best in the country. However, officials at Memorial Hermann told the Times that the data allegedly manipulated involved criteria for organ donors, which were set to impossible conditions such as a patient only accepting organs from a toddler who weighed 300 pounds.

The allegations have raised questions about what motivated Bynon to alter the data and whether other patients may have been affected. The hospital has not addressed when its transplant programs will resume, but it is working to “make the necessary changes that will allow for the quick reactivation of the kidney transplant program under a different physician leadership structure.”

The case highlights the importance of ethical behavior in the medical field and the potential consequences of falsifying patient data. It also underscores the need for transparency and accountability in ensuring that patients receive the best possible care and outcomes.